Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014


Drug Discovery & Development (DDD2014)

17 Jun 2014 - 18 Jun 2014 - Online Event



Bookmark and Share


SELECTBIO is pleased to invite you to attend the first of our innovative online conferences; Drug Discovery & Development (DDD 2014). Using a pioneering new platform especially developed for scientific events, this event will be broadcast to your PC or mobile device on 17th-18th June 2014.

During this event, the hottest topics in Drug Discovery will be addressed in a webinar-style auditorium with the opportunity for live Q&A at the end of each talk. Featuring an array of leading international speakers, this event aims to provide you with an insight into the latest developments in the design and development of drugs. Focus will be given to current developments in screening design, assay technology and compound management, as well as the emerging use of nanotechnology for drug delivery. Presentations will also highlight the increasing importance that academic centres play in drug discovery efforts, including drug repurposing and drug discovery for orphan diseases.
   
Benefits of attending this online event:

-    Opportunity to view posters, including an interactive session with the poster presenters.
-    Access to a virtual exhibit hall, enabling you to catch up with the latest technological developments in the industry via video, downloadable applications, brochures and interaction with booth staff.
-    View others in attendance and chat with them privately or in open forums.
-    No costs! No expensive flights, hotels or delegate fees.
-    Come & go as you please to fit around your busy life - you can attend at home or work using a PC or mobile device.

You can present your research on a poster while attending the meeting. Submit an abstract for consideration now!  Poster Submission Deadline: 06 June 2014





Further information
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!